Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← Seth Klarman, latest 13F

Seth Klarman · Q1 2017

Baupost Group

Portfolio at the end of Q1 2017, from the 13F filed May 25, 2017, as amended. See the filing on EDGAR ↗

CompanyWeightValueSharesPriceHeld sinceChange
Cheniere Energy LNG · history 12.1% $1.03B 21,726,340 $47.27 Q1 2014 No change
Viasat VSAT · history 9.9% $839.8M 13,158,137 $63.82 Q2 2013 or earlier No change
Twenty-First Century Fox FOXA · history 7.3% $619.9M 19,137,469 $32.39 Q3 2015 No change
Colony NorthStar CLNS · history 7.3% $618.5M 47,905,461 $12.91 Q1 2017 Buy
Synchrony SYF · history 7.1% $605.9M 17,665,000 $34.30 Q3 2016 Reduce 15%
Allergan AGN · history 6.8% $581.2M 2,432,603 $238.92 Q1 2016 Reduce 29%
Qorvo QRVO · history 5.8% $492.6M 7,185,514 $68.56 Q1 2017 Buy
Dell Technologies DELL · history 4.3% $362.2M 5,652,459 $64.08 Q3 2016 Reduce 15%
PBF Energy PBF · history 4.1% $348.6M 15,724,175 $22.17 Q3 2013 No change
Theravance Biopharma TBPH · history 4.0% $341.5M 9,273,991 $36.82 Q2 2014 No change
Antero Resources AR · history 3.9% $330.9M 14,505,881 $22.81 Q3 2014 No change
Qualcomm QCOM · history 3.5% $299.1M 5,216,000 $57.34 Q1 2017 Buy
Twenty-First Century Fox FOX · history 2.7% $231.3M 7,278,100 $31.78 Q3 2015 No change
Innoviva INVA · history 1.9% $160.1M 11,573,663 $13.83 Q2 2013 or earlier Reduce 22%
Keryx Biopharmaceuticals KERX · history 1.9% $158.9M 25,791,678 $6.16 Q1 2014 No change
Veritiv VRTV · history 1.9% $157.7M 3,044,385 $51.80 Q3 2014 No change
McKesson MCK · history 1.7% $148.3M 1,000,000 $148.26 Q4 2016 No change
Forward Pharma FWP · history 1.4% $119.9M 5,575,407 $21.51 Q4 2014 Add 4%
Atara Biotherapeutics ATRA · history 1.3% $110.1M 5,359,632 $20.55 Q4 2014 No change
Cardinal Health CAH · history 1.0% $84.0M 1,030,000 $81.55 Q4 2016 No change
Express Scripts ESRX · history 1.0% $81.0M 1,228,619 $65.91 Q1 2017 Buy
Silver Run Acquisition II SRUN.U · units · history 0.8% $69.0M 6,615,554 $10.43 Q1 2017 Buy
Liberty Ventures LVNTA · history 0.8% $65.9M 1,481,719 $44.48 Q4 2016 No change
ChipMOS IMOS · history 0.7% $62.3M 3,509,858 $17.75 Q2 2013 or earlier No change
Credit Acceptance CACC · history 0.6% $48.7M 244,400 $199.41 Q2 2016 No change
Atlanta Braves Holdings BATRK · history 0.6% $47.2M 1,994,010 $23.65 Q2 2016 Reduce 33%
Syngenta SYT · history 0.6% $46.7M 527,968 $88.50 Q4 2016 Reduce 29%
Novagold Resources NG · history 0.5% $46.3M 9,500,000 $4.87 Q2 2013 or earlier No change
GTY Technology GTYH.U · units · history 0.5% $45.4M 4,400,000 $10.32 Q4 2016 No change
Cencora COR · history 0.5% $44.5M 502,474 $88.50 Q4 2016 No change
Permian Resources CDEV · history 0.5% $41.7M 2,407,153 $17.31 Q4 2016 No change
Paratek Pharmaceuticals PRTK · history 0.5% $39.4M 2,044,498 $19.25 Q4 2014 No change
Conyers Park Acquisition CPAA · history 0.5% $39.4M 3,712,500 $10.60 Q3 2016 No change
Theravance Biopharma TBPH.CV · convertible notes · history 0.4% $37.8M 30,000,000 prn Q4 2016 No change
Cascadian Therapeutics CASC · history 0.4% $36.1M 8,721,079 $4.14 Q2 2016 Add 109%
American International Group AIG.WS · warrants · history 0.3% $26.9M 1,259,012 $21.37 Q2 2013 or earlier Reduce 51%
Saban Capital Acquisition SCAC · history 0.3% $23.2M 2,326,500 $9.99 Q4 2016 No change
Innoviva INVA.CV · convertible notes · history 0.3% $21.4M 22,480,000 prn Q3 2014 Reduce 51%
Sunrun RUN · history 0.2% $15.4M 2,848,082 $5.40 Q3 2015 No change
Orexigen Therapeutics OREX · history 0.1% $7.7M 2,226,839 $3.44 Q3 2015 No change
Trilogy Metals TMQ · history 0.1% $5.8M 10,600,758 $0.55 Q2 2013 or earlier No change
Conyers Park Acquisition CPAA.WS · warrants · history 0.0% $2.5M 1,237,500 $2.05 Q3 2016 No change
Saban Capital Acquisition SCAC.WS · warrants · history 0.0% $1.6M 1,163,250 $1.35 Q4 2016 No change
43 positions100.0%$8.49B

Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q4 2016, adjusted for stock splits.

Sector weighting

Sector weights in this 13F
Health care23.2%
Energy20.6%
Media & telecom20.5%
Financials & real estate16.9%
Technology14.9%
Industrials2.0%
Materials1.2%
Consumer discretionary0.8%

What changed from Q4 2016

← Q4 2016 Q2 2017 →